Overview

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Study to investigate the efficacy and safety of GL2702 GLARS-NF1tablet and Harnal-D - tablet in benign prostatic hyperplasia patients with lower urinary tract symptomatic
Phase:
Phase 3
Details
Lead Sponsor:
GL Pharm Tech Corporation
Treatments:
Tamsulosin